<SEC-DOCUMENT>0001683168-25-004784.txt : 20250627
<SEC-HEADER>0001683168-25-004784.hdr.sgml : 20250627
<ACCEPTANCE-DATETIME>20250627130424
ACCESSION NUMBER:		0001683168-25-004784
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250626
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250627
DATE AS OF CHANGE:		20250627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37487
		FILM NUMBER:		251084496

	BUSINESS ADDRESS:	
		STREET 1:		11555 SORRENTO VALLEY ROAD, SUITE 203
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		619-941-0360

	MAIL ADDRESS:	
		STREET 1:		11555 SORRENTO VALLEY ROAD, SUITE 203
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aemd_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:AEMD="http://aethlonmedical.com/20250626">
<head>
     <title>AETHLON MEDICAL, INC. 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_AEMD_aethlonmedical.com_20250626 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250626_20250626 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0000882291 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000004" name="dei:EntityCentralIndexKey">0000882291</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aemd-20250626.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882291</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-26</xbrli:startDate>
        <xbrli:endDate>2025-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>FORM <span id="xdx_900_edei--DocumentType_c20250626__20250626_zO1S0Y40UJOe"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20250626__20250626_zu6h2vqb0MZ1"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 26, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90B_edei--EntityRegistrantName_c20250626__20250626_zGbTLrJQBcwf" style="font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000011" name="dei:EntityRegistrantName">Aethlon
Medical, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 39%; font-size: 10pt; text-align: center"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250626__20250626_zJTuSlnV0UF3"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; font-size: 10pt; text-align: center"><b><span id="xdx_907_edei--EntityFileNumber_c20250626__20250626_z7UuPmL7oMUa"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000013" name="dei:EntityFileNumber">001-37487</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 39%; font-size: 10pt; text-align: center"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20250626__20250626_z5ve1Yeg9HE"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000014" name="dei:EntityTaxIdentificationNumber">13-3632859</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of
    incorporation)</p></td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p></td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 50%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20250626__20250626_z59cLmamThS2"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000015" name="dei:EntityAddressAddressLine1">11555
    Sorrento Valley Road</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20250626__20250626_z0FS5D53MO93"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
    203</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20250626__20250626_zhZTBLO7Weo2"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000017" name="dei:EntityAddressCityOrTown">San Diego</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20250626__20250626_zZLu2puW0cej"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 50%"><b><span id="xdx_907_edei--EntityAddressPostalZipCode_c20250626__20250626_zteZQmJWjaLb"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000019" name="dei:EntityAddressPostalZipCode">92121</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">(Address of principal executive offices)</td>
    <td style="vertical-align: top; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90D_edei--CityAreaCode_c20250626__20250626_z9KCwcbh1M8"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000020" name="dei:CityAreaCode">619</ix:nonNumeric></span>)</b><b> <span id="xdx_903_edei--LocalPhoneNumber_c20250626__20250626_zMqYmr3rTVkl"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000021" name="dei:LocalPhoneNumber">941-0360</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--WrittenCommunications_c20250626__20250626_zJWjii9u2BV9"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--SolicitingMaterial_c20250626__20250626_zNmiBR5MRAk9"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--PreCommencementTenderOffer_c20250626__20250626_zIKXZJlMFmv4"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20250626__20250626_zjouf73V2Jl7"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 40%; text-align: center">Title of each class</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 20%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trading Symbol(s)</p></td>
    <td style="border-bottom: Black 1pt solid; width: 40%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Name of each exchange on which registered</p></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--Security12bTitle_c20250626__20250626_zC6UPGxNXudf"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.001 par value per share</ix:nonNumeric></span></b></p></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; text-align: center"><b><span id="xdx_903_edei--TradingSymbol_c20250626__20250626_zlFplbZvzkmb"><ix:nonNumeric contextRef="AsOf2025-06-26" id="Fact000027" name="dei:TradingSymbol">AEMD</ix:nonNumeric></span></b></td>
    <td style="vertical-align: top; text-align: center"><b>The <span id="xdx_908_edei--SecurityExchangeName_c20250626__20250626_zIAR2CByh6o1"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250626__20250626_zpg7pM6TsMy9"><ix:nonNumeric contextRef="AsOf2025-06-26" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 2.02 Results of Operations and Financial
Condition.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information provided
below in &#8220;Item 7.01 - Regulation FD Disclosure&#8221; of this Current Report on Form 8-K (this &#8220;Current Report&#8221;) is
incorporated by reference into this Item 2.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June 26, 2025, Aethlon
Medical, Inc. (the &#8220;Company&#8221;) issued a press release regarding its financial results for the quarter ended March 31, 2025.
A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information set forth
under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to
the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference
language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed
an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 9.01 Financial
Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 72px"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td style="vertical-align: top; width: 14px">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="aethlon_ex9901.htm">Press Release, dated June 26, 2025.</a></span></td></tr>
  <tr>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL Document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: June 27, 2025</span></td>
    <td colspan="2"><span style="font-size: 10pt"><b>Aethlon Medical, Inc.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 52%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 43%"><span style="font-size: 10pt">/s/ James B. Frakes</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Name:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">James B. Frakes</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Chief Executive Officer and Chief Financial Officer</i></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>





<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUyX6sHHpCKyEInodckxlnRHZrfST+ovW5VouDAM9565QszEjra6RobrusjgjE1bK4dQYIWM5oY+ke4PCfhd4F1bx8q48fyBKXkGPbMMpVTeGKMvbbFMIFrM5SCIVkkcQ34UweCnZCpdonFa1aBMCTlTyxqd4n76cFYdGWr6seqCbDWZBOIwmuwPyCiWcKKXehM/LGRZKoLZOIHYMT1bn9p0Ds1AwqbGxtfZif4r+AIFFUqK -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aethlon_ex9901.htm
<DESCRIPTION>PRESS RELEASE, DATED JUNE 26, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 54.75pt; width: 144.75pt"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Earnings Script</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Aethlon Medical
Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Three Patients Treated in Hemopurifier&reg;
Cancer Trial; Indian Regulatory Approval Achieved; Operating Expenses Reduced; R&amp;D Advances Support Expanded Indications Including
Long COVID</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><I>Conference Call
to be Held Today at 4:30 p.m. ET</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SAN DIEGO, June 26, 2025 -- Aethlon
Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer
and life-threatening infectious diseases, today reported financial results for its fiscal fourth quarter ended March 31, 2025, and provided
an update on recent developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Key Fiscal 2025 Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&#160;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">First three patients treated in Hemopurifier&reg; cancer trial at Australian
sites</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indian regulatory approval
received to initiate a similar oncology study</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Study protocol expanded
to reflect evolving immunotherapy standard of care</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical data demonstrate
98.5% removal of platelet-derived EVs in simulated Hemopurifier&reg; treatment</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration with UCSF
to investigate Long COVID with findings to be presented at the Keystone Symposium</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 94%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses reduced
significantly through streamlined operations</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Clinical Progress in Cancer Trial</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aethlon completed Hemopurifier treatments in the
first three participants enrolled in its safety, feasibility, and dose-finding study of patients with solid tumors unresponsive to anti-PD-1
agents. Participant #1 was treated at Royal Adelaide Hospital in January 2025, while Participants #2 and #3 received treatment at Royal
North Shore Hospital in Sydney in June 2025. All participants completed a single 4-hour Hemopurifier treatment without device deficiencies
or immediate complications and have now completed the pre-specified 7-day safety follow-up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This milestone triggers the first meeting of an
independent Data Safety Monitoring Board (DSMB), to review safety data and recommend advancement to the second treatment cohort. In the
next cohort, participants will receive two Hemopurifier treatments during a one-week period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Preliminary data from the first cohort, including
effects on extracellular vesicle (EV) removal and anti-tumor T-cell activity, are expected in approximately three months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In parallel, the trial protocol was amended to
broaden eligibility to include patients receiving combination therapies with Pembrolizumab (Keytruda&reg;) or Nivolumab (Opdivo&reg;),
in line with current treatment practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, only about 30% of patients receiving
pembrolizumab or nivolumab experience lasting clinical responses. EVs released by tumors have been implicated in cancer progression and
resistance to anti-PD-1 therapies. The Hemopurifier&reg; is designed to bind and remove these EVs from the bloodstream, potentially improving
the therapeutic response rates to anti-PD-1 antibodies. In preclinical studies, the Hemopurifier has been shown to reduce the number of
EVs in cancer patient plasma samples.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a reminder, the primary endpoint for the approximate
9 to 18-patient study is safety. The trials will monitor any adverse events and clinically significant changes in lab tests of Hemopurifier
treated patients with solid tumors with stable or progressive disease at different treatment intervals. Patients who do not respond to
the PD-1 antibody therapy will be eligible to enter the Hemopurifier period of the study where sequential cohorts will receive 1, 2, or
3 Hemopurifier treatments during a one-week period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to safety, the study includes exploratory
analyses evaluating how many Hemopurifier&reg; treatments are needed to decrease the concentration of EVs, and if these changes in EV
concentrations improve the body&rsquo;s own natural ability to attack tumor cells. These findings are intended to guide the design of
future safety and efficacy trials, including a potential Premarket Approval (PMA) study required by the FDA and other global regulatory
agencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Regulatory Approval India</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 19, 2025, the Company received formal
approval from India&rsquo;s Central Drugs Standard Control Organization (CDSCO) to initiate a similar trial at Medanta Medicity Hospital.
The approval followed a meeting with the Subject Expert Committee and prior Ethics Committee clearance. The trial will begin following
a Site Initiation Visit (SIV) conducted by Aethlon&rsquo;s India-based CRO, Qualtran.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preclinical Study Supports Broader Applications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2025, the results from Aethlon&rsquo;s
preclinical ex vivo study were published in bioRxiv, and the manuscript has been submitted to a peer-reviewed journal for publication.
Those results showed that the Hemopurifier, using proprietary Galanthus nivalis agglutin (GNA) affinity resin, removed 98.5% of platelet
-derived extracellular vesicles (PD-EVs) from human plasma during a timepoint equivalent to a 4-hour HP treatment. Excessive levels of
PD-EVs have been implicated in a myriad of diseases, including cancer, lupus, systemic sclerosis, multiple sclerosis, Alzheimer&rsquo;s
disease, sepsis, acute and Long COVID. The results of this study support the ongoing oncology trial in Australia and suggest potential
applications of the Hemopurifier in other EV-associated diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The manuscript describing this study has been
submitted to a peer-reviewed journal for publication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Scientific Collaboration in Long COVID Research</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aethlon&rsquo;s collaborative research with the
UCSF Long COVID Clinic was accepted for a poster presentation at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
(August 10-13, 2025). The study analyzed blood samples from participants with Long COVID as well as controls that had recovered from COVID-19
infection to evaluate the binding of larger and smaller extracellular vesicles to the Hemopurifier&rsquo;s lectin affinity resin, respectively.
These findings build on prior clinical evidence and support further investigation of the Hemopurifier in Long COVID, an unmet medical
need affecting approximately 44 and 48 million people in the United States alone, with an estimated economic burden of 2 billion dollars
in those with symptoms lasting a year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operational Achievements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In fiscal 2025, Aethlon streamlined operations
and significantly reduced its operating expenses, positioning the company for sustained focus on its clinical and regulatory goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Financial Results for the Fiscal Fourth Quarter
Ended March 31, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025, Aethlon had a cash balance
of approximately $5.5 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated operating expenses for the fiscal
year ended March 31, 2025, were approximately $9.3 million, representing a decrease of $3.3 million or approximately 26%, compared to
$12.6 million for the fiscal year ended March 31, 2024. This reduction was primarily driven by lower payroll and related expenses, professional
fees, and general and administrative costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payroll and related expenses declined by an approximate
$1.3 million, reflecting an approximate $900,000 reduction in salaries and related expenses and an approximate $800,000 decrease in stock-based
compensation. These reductions were primarily attributable to the termination of three executives&mdash;one in the fiscal year 2024, one
in July and October 2024&mdash;and a workforce reduction of non-executive staff in August 2024. The decrease in stock-based compensation
was primarily due to the absence of accelerated vesting charges recognized in the prior year related to the termination of our former
Chief Executive Officer, as well as reduced expenses following the departure of executives and staff. These decreases were partially offset
by an increase of approximately $400,000 in severance expenses associated with the termination of two former executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Professional fees also declined by approximately
$1.3 million. This decrease includes $600,000 in legal costs savings resulting from a transition to a new legal firm, and an approximate
$500,000 related to the termination of services with a contract manufacturing organization and the completion of a project that involved
using an outside lab to process samples. Consulting fees related to scientific projects and regulatory projects declined by approximately
$300,000. These reductions were partially offset by an approximate $85,000 increase in accounting fees associated with obtaining audit
firm consents for various securities filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses decreased
by approximately $660,000. The reduction was driven primarily by a $534,000 reduction in costs related to fewer raw material purchases,
no cleanroom certification expenses, and reduced reliance on outside services for maintenance of the manufacturing facility. Laboratory
supplies and testing costs also declined by $337,000 following the completion of oncology and transplant-related projects. Insurance expenses
decreased by $141,000, reflecting lower medical and workers&rsquo; compensation premiums due to reduced headcount, as well as an overall
decrease in business insurance costs. Additional reductions included $44,000 in travel and entertainment expenses, $24,000 decrease in
office supplies, and $19,000 in depreciation expense related to the disposal of certain equipment. These decreases were partially offset
by a $467,000 increase in clinical trial expenses associated with our ongoing oncology study in Australia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the above factors, our operating
loss decreased to $9.3 million for the fiscal year ended March 31, 2025, from $12.6 million for the fiscal year ended March 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Income (Expense)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other expenses for the year ended March 31, 2025,
included a non-cash charge of approximately $4.6 million related to a warrant inducement offer. In March 2025, we offered certain warrant
holders the opportunity to exercise existing warrants at a temporarily reduced exercise price in exchange for the issuance of new warrants.
The inducement expense recognized represents the combined fair value of the new warrants issued and the incremental fair value resulting
from the modification of the exercise price of the existing warrants. This transaction did not impact cash flows from operating activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the fiscal year ended March 31, 2025, we
recognized approximately $324,450 in other income related to the Employee Retention Tax Credit (ERTC) under the CARES Act and subsequent
legislation. We recorded the ERTC as other income in the periods in which the payments were received. In addition, we recognized $36,339
in interest income related to the ERTC during fiscal 2025. As of March 31, 2025, the remaining expected credit was recorded as a receivable
within other current assets on our consolidated balance sheet. No amounts were recorded in the prior fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated balance sheets for March 31,
2025 and March 31, 2024, and the consolidated statements of operations for the fiscal years ended March 31, 2025 and 2024 follow at the
end of this release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Conference Call</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management will host a conference call today,
Thursday, June 26, 2025, at 4:30 p.m. ET to review the company&rsquo;s financial results and recent corporate developments. Following
management&rsquo;s formal remarks, there will be a question and answer session.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interested parties can register for the conference
call by navigating to https://dpregister.com/sreg/10200578/ff60012c0c. Please note that registered participants will receive their dial-in
number upon registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interested parties without internet access or
unable to pre-register may dial in by calling:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PARTICIPANT DIAL IN (TOLL-FREE): 1-844-836-8741</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All callers should ask for the Aethlon Medical,
Inc. conference call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A replay of the call will be available approximately
one hour after the end of the call through July 26, 2025. The replay can be accessed via Aethlon Medical&rsquo;s website or by dialing
1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll-free at 1-855-669-9658. The replay conference ID number is
4903201.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Aethlon and the Hemopurifier&reg;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aethlon Medical is a medical therapeutic company
focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening
viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening
viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing
its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression
and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated
Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant
of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of
the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application
related to the treatment of life-threatening viruses that are not addressed with approved therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information can be found at www.AethlonMedical.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that
involve risks and uncertainties. Statements containing words such as &quot;may,&quot; &quot;believe,&quot; &quot;anticipate,&quot; &quot;expect,&quot;
&quot;intend,&quot; &quot;plan,&quot; &quot;project,&quot; &quot;will,&quot; &quot;projections,&quot; &quot;estimate,&quot; &quot;potentially&quot;
or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties
and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements
are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors
that may contribute to such differences include, without limitation, the Company's ability to raise additional capital on terms favorable
to the Company, or at all; the Company&rsquo;s ability to successfully complete development of the Hemopurifier; the Company&rsquo;s ability
to successfully demonstrate the utility and safety of the Hemopurifier in cancer and infectious diseases and in the transplant setting;
the Company&rsquo;s ability to achieve and realize the anticipated benefits from potential milestones; the Company&rsquo;s ability to
obtain approval from the Ethics Committee of its third location in Australia, including on the timeline expected by the Company; the Company&rsquo;s
ability to enroll additional patients in its oncology clinical trials in Australia and India, including on the timeline expected by the
Company; the Company&rsquo;s ability to manage and successfully complete its clinical trials; the Company&rsquo;s ability to successfully
manufacture the Hemopurifier in sufficient quantities for its clinical trials; unforeseen changes in regulatory requirements; the Company&rsquo;s
collaborative research with UCSF Long Covid Clinic; the Company&rsquo;s ability to further research potential applications of the Hemopurifier
in other EV-associated diseases and other potential risks. The foregoing list of risks and uncertainties is illustrative but is not exhaustive.
Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under
the caption &quot;Risk Factors&quot; in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and in the Company's
other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements
contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does
not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contact:</B><BR>
Jim Frakes<BR>
Chief Executive Officer and Chief Financial Officer<BR>
Aethlon Medical, Inc.<BR>
Jfrakes@aethlonmedical.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B><BR>
Susan Noonan<BR>
S.A. Noonan Communications, LLC<BR>
susan@sanoonan.com<BR>
<BR>
</P>
<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Condensed Consolidated Balance Sheets</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Unaudited</P>


<P STYLE="margin: 0"><B></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2025</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD COLSPAN="8" STYLE="text-align: center"><B>ASSETS</B></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">5,501,261</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">5,441,978</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">277,827</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">448,539</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">505,983</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">TOTAL CURRENT ASSETS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,949,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,225,788</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,015,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">601,846</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">883,054</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Patents, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,100</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,813</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,506</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt">Deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">33,305</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">33,305</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,359,534</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,245,982</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">534,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">777,862</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Due to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">579,565</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">546,434</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Operating lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">313,033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">290,565</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued professional fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">472,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">215,038</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">TOTAL CURRENT LIABILITIES</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,899,286</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,829,899</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Operating lease liability, less current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">336,718</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">649,751</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,236,004</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,479,650</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Common stock, $0.001 par value; 60,000,000 shares authorized as of March 31, 2025 and 2024; 2,585,239 and 328,716 shares issued
    and 2,010,739 and 328,716 outstanding as of March 31, 2025 and March 31, 2024, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,586</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">329</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,092,894</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,339,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,133</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,940</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(167,954,817</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(154,566,728</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">TOTAL STOCKHOLDERS' EQUITY</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,123,530</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,766,332</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,359,534</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,245,982</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;Consolidated Statements of Operations and Comprehensive Loss</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">For the fiscal years ended March 31, 2025 and 2024</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Unaudited</P>


<P STYLE="margin: 0"><B></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Fiscal Year</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Fiscal Year</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Ended 3/31/25</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Ended 3/31/24</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Professional fees</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">2,224,092</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">3,526,926</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Payroll and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,874,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,206,451</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,243,181</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,903,191</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,341,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,636,568</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">OPERATING LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,341,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(12,636,568</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">OTHER EXPENSE (INCOME), NET</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(298,122</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(447,356</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Other income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(324,450</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,109</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,659,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18,962</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other expense (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,046,725</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(428,394</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,388,090</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,208,174</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share attributable to common stockholders</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8.58</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(38.87</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,560,839</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">314,097</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,388,090</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,208,174</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">OTHER COMPREHENSIVE INCOME/(LOSS)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(10,193</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(799</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">COMPREHENSIVE LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(13,398,283</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(12,208,973</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aemd-20250626.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaKLGaPty5522YkxvmR4fdlqXyMtq7h6RieahZH2AX8L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:AEMD="http://aethlonmedical.com/20250626" elementFormDefault="qualified" targetNamespace="http://aethlonmedical.com/20250626">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://aethlonmedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20250626_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20250626_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aemd-20250626_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aemd-20250626_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="aemd-20250626.xsd#Cover" roleURI="http://aethlonmedical.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://aethlonmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH CYI:9(PC4L3@5\3?M.?MH-H,UUX7\"7"S:@I\J]UI#OCMO\
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MZ--=Z')XF\0ZS*_V'1X;O[,#%&5,TKS;'V*-RX&T[B?9BOC_ ,6-6\)?MC?
M6V^+O@.&5=2T5WBO+.94%S$B'=+#-MS]P/YJG/W7?^_7O9/Q-B8XB,,3/FC(
M\C,LEIQI>TH_9/C_ )HYHYHYK]HIU/:+FB?!:AS1S1S1S75J&H<T<T<T<UG*
M/-$-3[T_X)]_&!M<\/W_ (#U*7==:6OVJP=F^_;NWSI_P!V_\?Q_#7V9QUK\
M<_@SX^;X:_$[P_XA5V2&UN$^UIUW6[_),?\ OEWK]@K69+FWCD!W*PW*RU_/
M7$V7_4<7S0^&6O\ F?I>1XOV]#V<MXEZBBBODSZ8***XKXL>-D^&OPM\7^+F
MMOMH\/Z/=ZM]EW;?.^SPO-LW>^S% '9[:-M?BQ??\%/OVE_C-J1TGX>Z+:Z=
M>_?CM_"NA/J5YLW?Q";SMWU"+6E;W7_!0SXA6?\ :2?\)E:QC^"2*STE_F_Z
M8L(F_P#':!<Q^R]%?A]XP_:&_;@_9YC:7Q5J'BK2+)9 &OM6TBWO+3<_1/M+
MPNG\/0/7TA^Q_P#\%4KCXF>-M'\$_%31[#3M1U:Y2UT[7M'5HK<SM@(EQ$[M
MM+N,;TXW.GR*/GH&?I8N-M)N]%S2M[]*^?\ ]H3]JS0?@G&ECY7]L>(9DWQ:
M;#*%V)_?E?\ @%:T:-3$34*<;LY\1B*>'ASU&>]+-N4\8IZR?+[5^;UK^TQ\
M?/C)JCP>%HYH8UX>'1=-1TC_ -^9]^S_ +[K4OM8_:M\%VK7UPNL/ OSLL=O
M9WW_ (XF]Z[Y9?**M.24NU]3S?[2C)<\8OE]#]$/PI=U?"_P?_X* 7$VI0Z;
M\0;&&"!WV?VQ8HZ^5_UVA/\ Z&G_ 'Q7LW[8GQJU?X/_ +*OBOXB>#;BS?5]
M/CL7LKF9!<0D37D$);_:^25JY*V'J47RS5CJP^*IXA7@SY__ ."HW[57Q+_9
MQNOA]9_#S78= .L17DMW,;*"Y=O*,&P#SHW51\[]*W_^"5_Q4\7_ !F^$?CG
M7/&GB._\2ZH?$C1K/?2%_+3[-"=B+]U$Y/RIZFORH_:&_:J^('[3UQHEUX[O
M+.Z?1TFCM/L=HEN%\S9O^[U^XGY5M_L__ML?%']F7PS?Z%X&O]/M=-O[O[9,
MEY8I/^^V(G#'_91:YCN/Z(Z_/W_@M-_R:SX7_P"QSM?_ $BOZ^:/@/\ \%/O
MCAX^^.7P\\,:SJ6BSZ3K?B+3],NTCTM$?RIKE(GV-V.U^M?2_P#P6F_Y-9\+
M_P#8YVO_ *17]!1\L_\ !%G_ ).F\4?]B9=?^EMA7[45^'__  2/\9:/X!^/
M'COQ'X@OH],T?3? ]Y<75U-]R)%O;#FN[^/W_!83QAKFH76F?";3H/"VCQDJ
MFM:M;I<W\W/WDB8M%$.3\K>9T'*_=H _86BOY]M:_;<_:?OK5=<O_B!XIMM.
MFX2\M[5;:V;_ '=D:)^5=+X!_P""J7[0/@W4(I-1\2V?BZQ1-@L=:TZ'83_>
M,D*I+N_X'0!^\E%?-_[)?[8WAO\ :T\)W>H:/9RZ1KVE[%U31[IP[VQ?E&1Q
M_K(FVM\_RGY/N5](4 ?SX?\ !23_ )/;^*/_ %]VW_I'!7[%?\$_?^3-?A3_
M -@D?^C'K\=?^"DG_)[?Q1_Z^[;_ -(X*_8K_@G[_P F:_"G_L$C_P!&/0!]
M"T45^?'[6W_!4KP]\'=<U#PE\.M/M_&7BFR<I<:E<2,-,M)03NC^3YIG7^((
MR*/[Y.Y* /T'HK\'6_;R_:K^,VH7EKX=\1:Q=%3YIL/"6B19ME_WHH6EV?+_
M !/3-6_:X_;!^#OER>(O$/C/PXMP^Q/^$FT10KOM^ZOVF _I0!^\M%?E?^SG
M_P %B'OM2ATGXSZ+9V-I+A5\1Z##*/)'RC,UO\[-_$Q>(]P!'WK],M!URP\2
M:'9:KIE[#J&G7\27%K=V\BRQ7$++N21&7AE9<$'O0!O45R?Q&UJ?PWX!\2ZQ
M9[/MNGZ9<W4.Y=R[XX7=?Y5^2/P)_P""G'QT^(/QL^'?AC6-4T=])UOQ'IVF
MWB0Z4B.T,US'&^'[':] '[-45^=W[7G_  5*T_X-^*M1\%_#33K#Q)XGT^1X
M=1U74&=K"SF1_GA5(RC3/PX8[U5&Q]_Y]OPW>?MY?M1_$22:XL_&^O30V[;G
M30]+BA2+_9)AA_\ 0Z /WUHK^?KPW_P4D_:+\*^6(/B1<ZC#OWM#J5E;7.[_
M &2[Q;_^^6%?H!^Q7_P4ZM?V@/%%KX'^(.F6/AWQC>[O[.O-/\S[!J$G/[G8
MY=H9=F-OSLK_ #_=;8C@'Z"T44C?=- 'YQ?\%"O&#:M\5M*T.-\P:3IV]O\
M8EF?>_\ XXD-?+/->G_M*:Y_PD7QX\<76[=LU)K+'_7']S_[)7F'-?OW#>'5
M'!TUY7^\_*,RJ>TQ,F'-:WA'PK?^-O$VFZ%IL?F7U_<);1*>V_\ C_W*R>:^
MV_\ @G_\&1'#>_$+4[?YI ]II>]?X,_O9?Q/R?@]3G^91P>'E;=[>I&7X66*
MKQB?57PO\ V7PS\#Z/X;T],6VGV_E[RN/-?^-V]W<LWXUWE+Q25^"SE*I-SE
MU/U6G3C3CRQ'T445)J%8>N:YI_AG1]1UK5;N'3]+T^![J\O+APB0Q(I=W9O[
MJKDUN5^<7_!7#]IK_A"O -E\)=$NBNL>)D6ZU<QM\T.GH_RI[&9U_P"^(G!^
M_0!^<G[67Q^O/VEOC=K7C*Z\Z'3"?L>DVDQ^:UL4SY*-RWS'+.^"?G=Z]4_X
M)N_M(6WP!^.D&EZS<QQ^#O&*)I6JM)_JX9>?LT[>NQW9&S\H29V[5\?4G-/X
M0^+0_3W]ICX0M\'?BEJ-E#%Y>BWQ^UZ:W\ B;^#_ ( _R?\ ?%>2<U]+?!'Q
M</VWOV.5L[B0W_Q1^'NRV::1]\]TFS]RY9B6;SHD*/D_/+"S>E?-/-?MG"^9
M_6*'LI_''<_+<WP/U7$7A\,@YHYHYHYK](/!#FCFCFCFGJ+4.:_5W]E7Q<?&
MWP)\)7TI+W4%K]AFW'+;X7,1)^NQ6_&ORBYK] ?^"=.N->?#W7M+=]_V'5"R
M#^ZCPQ_^SH]?E'&6']I2C5_E9]/P_6]G7Y/YC[#HHHK\@/TH*YSQAX5TKQUX
M9U/0-<L5U#1]2MWMKNUD9MLL3C#J=M='10!S'@WP3X>^'NBII/AG1=-\/:5$
MS.MCI5HEM"I)^8[$&,UT]?/WQB_;6^"_P-O+FP\5^.K&/687*/I.G[[R[C<?
M-LD2$/Y7_;3;7R1\0O\ @MAX:M5>/P'\.M4U1F3_ (^O$5VEFJ/_ -<H?.WC
M_@:4 ?HKXLL=%U3PSJ=EX@M[6ZT"XMG2_AOU5K9K?;\_F;OEV;<YK^9_Q<^F
M6OB[5CX;EN&T2&^F_LR:X&R;[.)#Y+/Z-LV5]=>)OCE^U-^WM:OX?T72+VZ\
M,S%4N=.\,V7V+2BZ@_\ 'S<R/]#LEFV_(AVYKY%\9>%;KP3XNUOP[>O%+?:/
M?3:?<-"V]&>)W1BA[K\M ']'7CSXC0_#_P"$^H>+K_:_V73EN1&?D$LS*-B?
M\"=D7\:_-#X9^$]7_:$^,UM::G>RS3:K<-=ZG>?QI"GSO_\ $)_P"OKG]N#6
M)]-_9ST&"(?N]1O+&VF_W!$\P_\ 'XDKX^^"/B[QIX'\17>J^"=%FU?4VM?L
MTNS3WN]D+NC_ '$^Y]ROILOHNGAI5H.TGIZ'R.85N?$1IR^%'ZE^#?!ND>!]
M#M-(T;3XM/T^T39%#"N .!_WTW^U74-&K=>:^!/^&G/VCO\ H3;C_P )VYIO
M_#3'[17_ $)MU_X3MS7FRPM2I+F<U]YV1Q5.*Y%!_<1?M[?".P\+ZQI/C'3+
M:.U75)GMK^-/D1[C[Z/_ +SKYF[V2O2_^"??Q&N_$G@G6O#%Y(T[Z+<(]J[]
M5MY=^$_X Z/_ -]"OG_XL>-/C9\:-!M=+\2>"=3%K;W:7B-:Z#<H^]$=/_9W
MKUW]@/P3X@\,^)/%LNLZ'J>D+);0JCZA:O#O^=_N;Z]'$4U]5Y:LTY1VL]3F
MPLI_6>:$/<9X!_P7$_Y&3X1?]>FI_P#H=M7JG_!%+_DW_P :_P#8T/\ ^DMM
M7E?_  7"_P"1C^$7_7IJ?_H=M7JG_!%+_DW_ ,:_]C0__I+;5\T?4GZ)5^?O
M_!:;_DUGPO\ ]CG:_P#I%?U^@5?G[_P6F_Y-9\+_ /8YVO\ Z17]!1^2'PU\
M-Z_XZ\7:=X-\-^=)J7B2>'25MXY&2.<O,C(LW_3,.B.>R[-_\-?N_P#LO_L3
M?#S]F'0].&F:3:ZOXQ2+%[XGO[='NII<8;R2?]1'Z(G\(&\NWS5^97_!(/P;
M;>)OVO$O[C_6>'M O-4@_P!]C#;?^@7+U^X] !7YR_\ !3C]B_PEK'PIU;XK
M^$=&BT+Q3H.VXU.#3K94AU.V:3]X\B*-OFIOW^=U**ZOO^39^C5>+?MH?\FE
M_%[_ +%B_P#_ $2U 'X[?\$O_'5WX)_;(\%Q1736UGK27.DWR?\ /9'A=T3_
M +_)"W_ *_?*OYUOV#?^3POA+_V'(?Y/7]%- '\^'_!23_D]OXH_]?=M_P"D
M<%?L5_P3]_Y,U^%/_8)'_HQZ_'7_ (*2?\GM_%'_ *^[;_TC@K]BO^"?O_)F
MOPI_[!(_]&/0!YC_ ,%./VF-2^ /P+CTGP]?S:?XK\72O86MY"Q2:UMD0&YF
M1L</\\<8P49?/WKRE?G7_P $]_V2;/\ :F^*%VWB 2)X%\-I#<ZLD#B.2\=]
M_DVV_.]%?9)O=/X$QE&=&'HG_!9KQ)<:A^T=X9TGSYFLM/\ #4,B0-]Q)I;F
MYWNO^\B0_P#?%?6W_!'OPF=!_9/N-4;E]<\0W=XK;>?+1(8-O_?4+_\ ?5!!
M]C>#_!>A^ -!M]%\,Z/8Z#I%OS%8Z=;K#"N3\V$7C-:E]8V^K6<]K=P17-M.
MFR2&:/>CJ?X64_6M.B@L_'3_ (*:?L-Z/\'[5/BA\/--32_#%W<_9=9T>VC8
M0V,SGY)XEQ\D+M\FS[J,4V</A.^_X(^_M'7FH+JWP:UNX,UO9V[ZUH+L ?*3
MS,7-M]_^_*DJ*$_Y[$G[E?;G[:WANP\7?LF?%JROXUE@A\.7FH*K?\]K:(W,
M7_C\*5^)7[!?BYO G[87PGU,(SB;6DTW"K_S]J]I_P"UJ /WU^,'_))?&W_8
M#O\ _P!$/7\T7A[7M1\,:]I^MZ7<R66IZ?<)=VEU#P\4J.&1U^C 5_2[\8/^
M21^-O^P'??\ HAZ_FN^''A5_'GQ \,>&DE\EM:U.VTU9/[AFE6//_C] 'ZJ?
M\$[?^"??A2U^'NB_$WXCZ#;>(-=UJ%;_ $;2=05)[2TM'7]U,\7W)7='#_.#
ML!3A7SC])+>WBM(5AB18H47:B*N%5:@L[&#3;.&TM(U@M8$5(XHU^5%7@**T
M: /!_P!I#]E?P+^TUX3O-.\2Z)9Q:X('33_$2V_^F6,FT['#\,Z!NL3':V/I
M7\_NL:;KOPI\?7MA,[:7XE\-ZF\#R0O\]O=V\Q7Y&]4=/TK^GJOYKOVLO^3I
MOC)_V.6L?^ELU ']$WPS\81_$3X<^%?%4">7#KVE6FJ(O]U9H4E _P#'ZZ&Z
M_P"/5OI7F/[)O_)K/P<_[$W1_P#TBAKTZZ_X]6^E5'XB*GP,_&SXH3?:OB9X
MNG=-CRZM>/\ ^1GKF.:ZKXK6KVOQ2\8VK_\ +/6;Q/G_ .NSURO-?T#EM14\
M%!KL?E.*O[=G7_"GX=W_ ,4O'VD^&K'?&][+^^GV?\>\/WW?_OBOUT\)^&[#
MPCX?L-%T^!;:PL8$MX(4Z*BC %?,G[!OP9;POX/F\::A%LU77%_T7>,F*SZK
M_P!]M\W^ZL=?6VT9Q7Y)Q!F3QV*Y(_!'\S[/)\#]7I>UG\4B:BBBOESZ8***
M* .,^)'Q"T;X5^!=;\8>(;I;/1=(M7O;J;OL7^!,D;G;(5%_B9@!UK^<_P".
MWQ8U7XW?%KQ1XZU;<E[K5VTWDJ<K!$ $BA!]$B1$_P" 5^A/_!83]I*>2;2/
M@YHMP\=OM36=>97(\SG_ $:V.'[?/*Z.O_/ C[M?EGS0 <T<T<T<T ?1?[%?
M[1$_[,?QTTCQ%-(?^$:OO^)9KD?]ZS=AN<?(YW1-LF 3EO+V9^<U]G_MA?"%
M/A[\1/[=TU%?0/$F^\MWA^XLW_+9/_']Z?[_ /L5^5GG?>]Z_53]C'QU#^UE
M^S'K?P8UVY3_ (33P7!'<:'-/(H:2T3Y8,=6_=-^Y<[/D26'JU>_E..>!Q4*
MB^%_$>+FN#^L8?W?B/!N:.:FOK&XTZ\GM;N)X;JW=X9H738Z.GWTJ'FOZ#P=
M98B'/$_*Y7B[!S1S1S1S7IZD:AS7VS_P399OM'CZ,EMBC3F13V_X^?\ "OB;
MFOMK_@FW9RQMX[N67$,C6,:9_O)]I)_1DK\[XP_W1_+\T?09+_O,3[JHHHK\
M./U$*_+'_@J)^VMXD\)^*F^#W@;5;C1/)@BNM?U*QE>*Z=G&]+-'_P"6:;-C
MN5^^)%3[N\/^IU?@O_P52\.WVC_MJ>-;N[M9(+?5K73KVSD8<30BSAA+C_MK
M#*G_   T 6_V+_\ @GGXF_:FM3XHU6^D\*_#Z&X%O_: A+W6H,KXD2V3@84?
M*9G^56X"R;7"_J+\)?\ @GK\"/@_;POI_@:RU[5$C1&U3Q,/[1F=UR=^Q_W2
M/[Q(G2N-_P""8_Q0\,>,/V5?"N@Z)>6_]L>&_.L]5TJ-OWMN[S32),ZX^[,K
M;]WW=Y==Q9'K[*H JV]O%:0K#$BQ0HNU$5<*JU_-3^T9_P G!?$[_L9]4_\
M2J2OZ8*_F?\ VC/^3@/B9_V-&J?^E4E '[5_MM>'Y=8_9MTF\A_U>EW=C>O_
M +A1H?\ VLM>*?\ !/O7(K/XJ:UI#H -0TW>K'N\+IA/^^7;_OBOMK7O"-KX
M^^%;^'K\?Z+J6E+;.R8^7='C</\ =ZU^7]NWB7]G7XO1231>3K>@W6-BGY+F
M/_XAT_\ 0Z^FP'+6PTZ%_>W1\KCHNGB(5?LGZ^>6/0&E\E/3->7?"'XX>&/B
M]H\5[HM_%]JV!I]/F<"XMV]'3K_P*O3Q=)V>O J4ZM.3C)6:/;I5*52/,AWD
M)_=S^%2!57MBL/7/%&E>&=/>\U34[/3K1/O3WEPL48^K,:C\)^+-*\;:#;ZO
MHEW'J&F7#R+%<P_<?8[(^/\ @2,*AQE:[V-8RI\W+$_+[_@N)_R,GPB_Z]-3
M_P#0[:O5/^"*7_)O_C7_ +&A_P#TEMJ\N_X+>1O_ &]\(9 IVFWU10WOOMO\
M:T?^"-?QDT/2]+\7_#2]O;>SUR[ODU?3H)9 KWJF'9,D?'S,@B1MGHY/\+5F
M=!^J5?G[_P %IO\ DUGPO_V.=K_Z17]?<6O>)M(\,PQW&KZI9Z7!*ZPI)>3I
M"CNWW4^;N:^'?^"TW_)K/A?_ +'.U_\ 2*_H*/EG_@BS_P G3>*/^Q,NO_2V
MPK]J*_%?_@BS_P G3>*/^Q,NO_2VPK]J* &K7C'[:/\ R:7\7O\ L5[_ /\
M1+5[.M>,?MH_\FE_%[_L5[__ -$M0)GX?_L&_P#)X7PE_P"PY#_)J_HIK^=;
M]@W_ )/"^$O_ &'(?Y-7]%- S^?#_@I)_P GM_%'_K[MO_2."OV*_P""?O\
MR9K\*?\ L$C_ -&/7XZ_\%)/^3V_BC_U]VW_ *1P5^Q7_!/W_DS7X4_]@D?^
MC'H _.C_ (+0>%[O3_VBO">NF!EL-3\-) DW]^:&YG\Q?P26'_ONOJC_ ((^
M^-$\0?LNW^A/,OVOP_K]S!Y._+I#,B3(^W^$%WF'_ &KK_\ @I-^S+<?M$?
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M]F^^\.Z;JWQCURVEMFU2W.F:%%)T>VWAYKC9_MNB(AS_  2_WEH _0WXP?\
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M'P9T/PIX/GTRWU&S\00ZG(VK7+PQ^4EM<Q$ HCY;=,O;M7U;10!^='_!/?\
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MGQT\0:EXP\$7<?@_QA?.9KNVF3=I=_,-^7=4^>%W8IO=-V<9\O>[O7WKD4M
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M4 %%%% !1110!&O>OF3]NCP+KWCKX<Z'9^'=(NM9NH]729H;./>Z+Y,P+_\
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MGR[X=_:"^*GBJ/6KB?X47^C6EGI\LUNLT4SS7-U\B11IN1/XG.[Y.%1C7/\
M[%_P/U[0=6\2^,O&^ESVVMWDOV>!-2B'G?-AYIO^!OL_[X:OL-8QT(%*JC:1
MBD\4XPE&"4>:PU@N:<9U9<W*>#?M8?!]?B9\);ZSTRT6?6+&1;ZSCC4!Y'3[
MZ=/XD9_^!%:^<?$W@GXD>+/V4_#_ (5O?">K?VQHNO(D,+P-O>T\F;9)_P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I&QWI:* .'\:?"_PM\0(1!XA\/V&
MK(@^1[JW5W3_ '&^\OX5X/XL_P""??@/6)&ETBZU30G_ ((8;CSX5_!_G_\
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>EZGI4L/1H_PX6):***Q.L**** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 26,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aethlon
Medical, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3632859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11555
    Sorrento Valley Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
    203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">941-0360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AEMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="aemd_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aethlonmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aemd-20250626.xsd</File>
    <File>aemd-20250626_lab.xml</File>
    <File>aemd-20250626_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="aemd_8k.htm">aemd_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aemd_8k.htm": {
   "nsprefix": "AEMD",
   "nsuri": "http://aethlonmedical.com/20250626",
   "dts": {
    "schema": {
     "local": [
      "aemd-20250626.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "aemd-20250626_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aemd-20250626_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "aemd_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://aethlonmedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aemd_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aemd_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001683168-25-004784-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-004784-xbrl.zip
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MFKEC:DE >-A\=620X4AIO;"PV. T_;S-$DHR>"+25&Y9L%ILL]"2!,2"S1?
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MZV\#H]TR\Z8FM6D:%!H09V_Q"Q!XJ (UZOC0F+%\7LR3#XW+;&XL>EH\8G$
M;[=Y)F=080R^"MX9Y/CVPH &:#<9.B("0F^ 3>B&0Q&)BM /J Q&C6A/YV?9
M(0L@B3_O[\D#X?*]@R79Y9_%CIXZSC &Q+H^>QO<'/UDKC<P" C?ZA8ZU<M0
MLP*TDL^(556@WV4EJ*C%]OOES4W7XI/8K#:)OU8X(V++?P%02P,$%     @
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MM6WH*7Q3!"@.C0_J&X7 &$K"=-$^TG5K#[AWU1;?N%_N?:SVR/]02P,$%
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M^/;B A<3_HB:=U[)LR,OQE\U%P>@1*@W 0\Z%1=2*9FZF%CQ;,SRLS">=-G
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M* 7",WW7=F\"T1WX]B1DD/"E%X<LC:.M *@IPY'CN>*SM.R!Z60S3=?U(G<
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M#4'8^')/ *^1 *Z R1U@;K2EP(0TP7 <@_,5HBN<S33JQY5?@!#&Y.3!1D]
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MAFI  CHJ<DL>%H?CD1C(-30%ION"N!+"%"XLBE\<VO[86")" ))*+(KNH]Q
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M,#(U,#8R-BYX<V102P$"% ,4    " "+:-M:71??Y_T*  !_A@  %0
M        @ %= P  865M9"TR,#(U,#8R-E]L86(N>&UL4$L! A0#%     @
MBVC;6A$7LE=?!P  X%<  !4              ( !C0X  &%E;60M,C R-3 V
M,C9?<')E+GAM;%!+ 0(4 Q0    ( (MHVUK[>G!8;Q,  )1L   +
M      "  1\6  !A96UD7SAK+FAT;5!+ 0(4 Q0    ( (MHVUJZR(%,2"<
M &@@ 0 2              "  ;<I  !A971H;&]N7V5X.3DP,2YH=&U02P4&
2      4 !0 ^ 0  +U$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>aemd_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aemd-20250626.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
        </entity>
        <period>
            <startDate>2025-06-26</startDate>
            <endDate>2025-06-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-26" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-26" id="Fact000004">0000882291</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-26" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-26" id="Fact000010">2025-06-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-26" id="Fact000011">Aethlon Medical, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-26" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-26" id="Fact000013">001-37487</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-26" id="Fact000014">13-3632859</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-26" id="Fact000015">11555     Sorrento Valley Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-26" id="Fact000016">Suite     203</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-26" id="Fact000017">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-26" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-26" id="Fact000019">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-26" id="Fact000020">619</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-26" id="Fact000021">941-0360</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-26" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-26" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-26" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-26" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-26" id="Fact000026">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-26" id="Fact000027">AEMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-26" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-26" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
